1.Sales and profit
See section β- XCF Global, Inc. had $0.0M of revenue in fiscal 2025.
- XCF Global, Inc. made $74.0M of net profit in fiscal 2025.
SAFX Nasdaq Industrial Organic Chemicals Financials FY2024βFY2025
XCF Global, Inc. had $0.0M of revenue in fiscal 2025.
Last close Β· Oct 26, 2026
$0.16
β$0.89 (β85.07%) past year
Hi! I read XCF Global, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Does it make a profit?
$74.0M
Yes. It made $74.0M of profit last year.
How healthy are the accounts?
3 / 7
Weak. It passes 3 of 7 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA summarises the numbers
XCF Global, Inc. had $0.0M of revenue in fiscal 2025.
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Loss periods are shown in red.
KIRA summarises the numbers
XCF Global, Inc. made $74.0M of net profit in fiscal 2025.
Net income
Net income
Diluted EPS
Diluted EPS
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Dividends and buybacks
Diluted shares outstanding (annual)
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
KIRA summarises the numbers
In the last 12 months, insiders sold $6.3M of shares on the open market and bought none.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$6.3M
1 insider
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 15, 2026 | Randy Soule10% owner | Sold | 5,000,000 | $0.41 | $2.1M | Form 4 |
| Apr 30, 2026 | Randy Soule10% owner | Sold | 9,000,000 | $0.34 | $3.1M | Form 4 |
| Mar 12, 2026 | Randy Soule10% owner | Sold | 1,261,830 | $0.52 | $0.7M | Form 4 |
| Feb 25, 2026 | Randy Soule10% owner | Sold | 2,000,000 | $0.12 | $0.2M | Form 4 |
| Jan 14, 2026 | Randy Soule10% owner | Sold | 361,363 | $0.15 | $0.1M | Form 4 |
| Jan 13, 2026 | Randy Soule10% owner | Sold | 600,000 | $0.17 | $0.1M | Form 4 |
| Jan 12, 2026 | Randy Soule10% owner | Sold | 273,000 | $0.16 | $0.0M | Form 4 |
| Jan 9, 2026 | Randy Soule10% owner | Sold | 200,000 | $0.16 | $0.0M | Form 4 |
| Jan 8, 2026 | Randy Soule10% owner | Sold | 200,000 | $0.17 | $0.0M | Form 4 |
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably XCF Global, Inc. can carry it.
KIRA summarises the numbers
XCF Global, Inc. owes $124M more than it holds in cash.
Cash vs debt (incl. leases)
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $0.4M | $0.2M |
| Debt incl. finance leases | $0.2M | $124M |
| Debt / equity | 0.0x | 3.3x |
| Current ratio | 0.0x | 0.1x |
| Quick ratio | 0.0x | 0.1x |
| Total assets | $355M | $419M |
| Total liabilities | $313M | $382M |
| Shareholders' equity | $41.4M | $37.7M |
| Net debt (β = net cash) | β$0.2M | $124M |
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
KIRA summarises the numbers
Its return on capital was β33.2%: every 100 invested in the business earned about β33 in a year.
Return on capital, equity and assets (annual)
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
KIRA summarises the numbers
XCF Global, Inc. passes 3 of 7 financial health tests (Piotroski F-score).
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | β | β |
| Cash from operations is positive | β | β |
| Return on assets rose | β | β |
| Cash from operations exceeds net income | β | β |
| Debt fell relative to assets | β | β |
| Current ratio rose | β | β |
| Share count didn't rise | β | β |
| Gross margin rose | β | β |
| Revenue rose relative to assets | β | β |
| F-score | β / 3 | 3 / 7 |
| Accruals ratio | β3.7% | 23.7% |
| Altman Z'' | β3.84 | β4.58 |
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | $0.0M | $0.0M |
| Net interest income | β$2.9M | β$9.2M |
| Gross profit | β | β$3.8M |
| Operating income | β$21.2M | β$67.9M |
| Net income | β$24.1M | $74.0M |
| Diluted EPS | β | $0.52 |
| Diluted shares | β | 0.14B |
| Cash flow | ||
| Cash from operations | β$11.1M | β$17.9M |
| Capital expenditure | $28.7M | β |
| Free cash flow | β$39.8M | β |
| Stock-based compensation | $0.0M | $8.8M |
| Balance sheet | ||
| Cash and short-term investments | $0.4M | $0.2M |
| Total debt | $0.2M | $124M |
| Current assets | $1.4M | $27.6M |
| Current liabilities | $180M | $249M |
| Inventory | β | $0.3M |
| Property and equipment, net | $352M | $390M |
| Total assets | $355M | $419M |
| Total liabilities | $313M | $382M |
| Shareholders' equity | $41.4M | $37.7M |
| Returns | ||
| Return on capital | β40.6% | β33.2% |
| Return on capital employed | β12.2% | β39.8% |
| Return on equity | β58.2% | 187.1% |
| Return on assets | β6.8% | 19.1% |
| Return on tangible equity | β58.2% | 196.6% |
| Financial health | ||
| Debt / equity | 0.0x | 3.3x |
| Current ratio | 0.0x | 0.1x |
| Quick ratio | 0.0x | 0.1x |
| Quality scores | ||
| Piotroski F-score | β | 3.0 |
| Altman Z'' | β3.8 | β4.6 |
| Accruals ratio | β3.7% | 23.7% |
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
Source: SEC EDGAR XBRL filings (CIK 0002019793). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.